CARE Ratings is India's second-largest credit rating agency, generating the bulk of its revenue from assigning ratings to corporate bonds, bank loans, and structured finance instruments. In FY26, consolidated revenue grew 18% to ₹473 crore, with net profit of ₹174 crore, while the standalone domestic ratings business delivered a 48% operating margin and 39% PAT margin. The company holds a 24-25% share of incremental rating assignments by both count and debt volume, and its one-year rating stability rates in investment-grade categories have consistently matched or exceeded industry averages from 2022 through 2026. This margin level, sustained above 40% at the operating line, signals a high-quality franchise with pricing power and operating leverage, not a commodity scale game.
The durability of these economics rests on several underappreciated barriers. CARE is the only IFSCA-registered rating agency, making it the mandatory choice for all IFSC debt ratings since April 1, 2025, a regulatory moat that competitors cannot quickly replicate. In ESG ratings, it holds a 58% market share among Category 1 providers, and its African subsidiary commands 98% of the Mauritian market, while CARE Nepal is the country's number one agency. Switching costs are high because issuers rely on long-standing relationships and the analytical rigor that keeps default rates within RBI's prescribed benchmarks, as evidenced by the central bank's recent risk-weight alignment. The company's AI adoption, with 60% of employees using enterprise AI tools daily, further widens the cost advantage, making it difficult for smaller players to match its efficiency.
The inflection point is already underway. The commercial launch of PaRRVA in May 2026, the expansion of CareEdge Global to 45 sovereigns covering over 85% of global GDP, and the achievement of breakeven in the advisory and analytics subsidiary (CAAPL) in FY26 are the triggers that will reshape the business over the next 18-24 months. By FY28, non-ratings revenue, which crossed ₹50 crore in FY26 (up 19% YoY), should grow to roughly ₹80-100 crore as ESG ratings, analytics, and international operations scale, moving the mix from the current 89:11 toward the stated long-term target of 80:20. CareEdge Global, which has already rated US$8 billion of corporate debt, is expected to turn profitable in the ensuing years, and the ESG business, currently loss-making, should approach breakeven as the market matures. Consolidated operating margins, at 42% in FY26, should expand toward 45% as loss-making subsidiaries shrink and the high-margin core continues to benefit from AI-driven cost efficiencies.
Management's walk-talk has been largely consistent. In May 2025, they committed to outpace industry growth and deliver a CRM module in FY26; the module went live, and FY26 revenue grew 18% against a backdrop of declining corporate bond issuances (down 3.2% in FY26). They promised CAAPL breakeven in FY26, which was achieved, and PaRRVA's May 2026 launch was delivered as stated. The only slippage is the timeline for CareEdge Global profitability, which management has not dated but expects "in ensuing years." Capital allocation remains disciplined: the stake sale to SBI and NSE in CareEdge Global is in progress, with no dilution to existing shareholders, and the company has not committed to buybacks or subsidiary listings, calling them premature. The absence of numeric guidance is a limitation, but the qualitative commitments have been met or are on track.
The earnings path is visible. With core ratings growing at a high single to low double-digit rate (bank credit growth was 16.1% in FY26), non-ratings accelerating at 25-30% annually, and operating leverage from AI, consolidated PAT could rise from ₹174 crore in FY26 to ₹220-250 crore by FY28, assuming margins expand by 200-300 basis points. The key falsifier is a sustained contraction in the bond market: corporate bond issuances fell 11.3% in Q4 FY26, and if that deepens, rating revenue could stall. Additionally, the ESG market remains voluntary and dependent on regulatory catalysts, and CareEdge Global's profitability is not guaranteed. The tension between declining bond volumes and rising revenue is resolved by the company's structural shift toward bank loan ratings and market share gains, which have offset the bond weakness. The single most important watchpoint is whether CareEdge Global achieves profitability without further capital calls, as that would validate the international expansion thesis.
companyname: CARE Ratings Limited ticker: CARERATING sector: Financial Services - Credit Rating & Analytics CARE Ratings Limited (ticker: CARERATING) is India's second-largest credit rating agency, operating under the brand name CareEdge. Established in 1993, the company was licensed by SEBI and accredited by the RBI to assess the creditworthiness of corporate borrowers, financial institutions, and debt instruments. Over three decades it has completed over 1,01,111 rating assignments and serves...
Read the full report →regulatory approval, geographic expansion, margin expansion, new product segment
No guidance
Guidance no_datamixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for CARE Ratings Limited and 4,900+ companies.
5-day free pass. No card required.